NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market Wednesday that its second-quarter revenues declined 1 percent year over year, falling short of Wall Street estimates on the top line.

The Carlsbad, Calif.-based genetic analysis products firm reported total revenues of $945.8 million for the three months ended June 30, compared to $949.3 million for the second quarter of 2012. On average, analysts covering the firm expected revenues of $952.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.